SCHEMBL7452667

SCHEMBL7452667

CCOCn1cnc2c1c(=O)n(CCCCC(C)(C)P(=O)(OCC)OCC)c(=O)n2C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.48
▸ CYP1A2 P05177 2/20 0.48
▸ NFKB1 P19838 2/20 0.48
▸ ACHE P22303 2/20 0.48
▸ PDE4A P27815 2/20 0.48
▸ PMP22 Q01453 2/20 0.48
▸ ESR1 P03372 1/20 0.48
▸ MAPT P10636 1/20 0.48
▸ BLM P54132 1/20 0.48
▸ TNF P01375 4/20 0.45
▸ ADORA2B P29275 4/20 0.43
▸ ADORA2A P29274 1/20 0.43
▸ TRPA1 O75762 2/20 0.41
▸ USP2 O75604 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ PDE4B Q07343 1/20 0.41
▸ PDE4C Q08493 1/20 0.41
▸ PDE4D Q08499 1/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7457138 0.88 ADORA2B (0.53) LMNACYP1A2NFKB1ACHEPDE4A
Torbafylline SCHEMBL93832 0.86 PDE4A (0.53) LMNACYP1A2NFKB1ACHEPDE4A
SCHEMBL14507751 0.84 PDE4A (0.61) LMNACYP1A2NFKB1ACHEPDE4A
SCHEMBL7455411 0.84 PDE4A (0.51) LMNACYP1A2NFKB1ACHEPDE4A
SCHEMBL14507749 0.83 PDE4A (0.60) LMNACYP1A2NFKB1ACHEPDE4A
SCHEMBL7459491 0.83 PDE4A (0.50) LMNACYP1A2NFKB1ACHEPDE4A
SCHEMBL7453497 0.83 PDE4A (0.49) LMNACYP1A2NFKB1ACHEPDE4A
SCHEMBL7460637 0.82 PDE4A (0.54) LMNACYP1A2NFKB1ACHEPDE4A
SCHEMBL14507748 0.82 PDE4A (0.58) LMNACYP1A2NFKB1ACHEPDE4A
SCHEMBL8791833 0.82 PDE4A (0.53) LMNACYP1A2NFKB1ACHEPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0771813-B1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines HOECHST AG (DE) 2002-01-16 — — EP disclosed
US-5728686-A TREATMENT OF MUSCULAR DYSTROPHY HOECHST AKTIENGESELLSCHAFT (DE) 1998-03-17 — — US disclosed
EP-0771813-A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines HOECHST AKTIENGESELLSCHAFT (DE) 1997-05-07 — — EP disclosed
Send feedback